These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 12581971)

  • 21. Pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in therapy control of patients with small-cell lung cancer.
    Schneider J; Philipp M; Salewski L; Velcovsky HG
    Clin Lab; 2003; 49(1-2):35-42. PubMed ID: 12593474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Five tumor markers in lung cancer: significance of total and "lipid"-bound sialic acid.
    Kakari S; Stringou E; Toumbis M; Ferderigos AS; Poulaki E; Chondros K; Dema A; Kotsovoulou V; Pavlidis N
    Anticancer Res; 1991; 11(6):2107-10. PubMed ID: 1663720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Usefulness of a multiple biomarker assay in bronchoalveolar lavage (BAL) and serum for the diagnosis of small cell lung cancer.
    Nikliński J; Chyczewska E; Furman M; Kowal E; Laudanski J; Chyczewski L
    Neoplasma; 1993; 40(5):305-8. PubMed ID: 8272160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical evaluation of five tumor marker assay in patients with lung cancer.
    Mizushima Y; Tsuji H; Izumi S; Hirata H; Kin Y; Kawasaki A; Matsui S; Yano S
    Anticancer Res; 1991; 11(1):91-5. PubMed ID: 2018388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Role of biological tumor markers CEA, Cyfra-21, NSE, TU M2-PK in diagnosis and treatment of lung cancer].
    Lazarev SM; Massard Zh; Reshetov AV; Nikolaev GV; Volgin GN; Osipov EV; Lomteva EIu; Nokhrin AV; Kakysheva OE
    Vestn Khir Im I I Grek; 2010; 169(1):39-43. PubMed ID: 20387605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical evaluation of serum NSE and CEA in primary lung cancer patients].
    Fukasawa T; Fujisawa T; Yamaguchi Y; Sasaki K; Shiba M; Yusa T; Sakio H; Momiki S; Ogawa T
    Gan To Kagaku Ryoho; 1986 May; 13(5):1862-7. PubMed ID: 3010884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diagnostic value of biochemical tumor markers in brain tumors. Review of the literature and own experience with serum analysis of sialic acid (NANA), carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE)].
    Flaschka G; Marth E; Desoye G; Freidl W; Walzl M
    Zentralbl Neurochir; 1990; 51(3):129-37. PubMed ID: 2092546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Importance of serum TPA determination in bronchopulmonary cancer. A comparative study of CEA, CA 19.9 and NSE].
    Prévost A; Passemard F; Perdu D; Vallerand H; Deschamps F; Lavaud F; Larbre H
    Rev Mal Respir; 1994; 11(4):379-84. PubMed ID: 7973038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Usefulness of carcinoembryonic antigen (CEA), tissue polypeptide antigen (TPA), enolase (NSE) and thymidine-kinase (TK) in the monitoring and prognosis of primary carcinoma of the lung].
    De Angelis G; De Marinis F; Bigioni D; Migliorino MR; Alma MG; Pigorini F
    J Nucl Med Allied Sci; 1990; 34(4 Suppl):135-40. PubMed ID: 1965445
    [No Abstract]   [Full Text] [Related]  

  • 30. [Serial measurements of serum carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) during chemotherapy of patients with inoperable lung cancer].
    Fukuoka M; Takada M; Kamei T; Negoro S; Kusunoki Y; Matsui K; Ryu S; Sakai N; Takifuji N; Masuda N
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):871-80. PubMed ID: 3032108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic value of CEA, CYFRA 21-1, NSE and CA 125 assay in serum and pleural effusion of patients with lung cancer.
    Wu GP; Ba J; Zhao YJ; Wang EH
    Acta Cytol; 2007; 51(4):679-80. PubMed ID: 17718156
    [No Abstract]   [Full Text] [Related]  

  • 32. Carcinoembryonic antigen, neuron-specific enolase and creatine kinase-BB as tumor markers for carcinoma of the lung.
    Nikliński J; Furman M; Palynyczko Z; Laudański J; Bułatowicz J
    Neoplasma; 1991; 38(6):645-51. PubMed ID: 1766488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Lung cancer].
    Komagata H; Yoneda S
    Gan To Kagaku Ryoho; 2004 Oct; 31(10):1609-13. PubMed ID: 15508459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Tumor markers. I. Their significance in the preoperative assessment of lung neoplasms].
    Ratto GB; Capponi G; De Grandi R; Augeri C; Secco GB; Fardelli R
    Minerva Chir; 1990 Oct; 45(20):1265-72. PubMed ID: 1964495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative studies of CAM 123-6 and carcinoembryonic antigen for the serological detection of pulmonary adenocarcinoma.
    Kohno N; Hirasawa Y; Kondo K; Fujioka S; Fujino S; Abe M; Yokoyama A; Hiwada K; Watanabe K; Nishimura J
    Cancer Detect Prev; 1997; 21(2):124-8. PubMed ID: 9101072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nucleosomes, ProGRP, NSE, CYFRA 21-1, and CEA in monitoring first-line chemotherapy of small cell lung cancer.
    Holdenrieder S; von Pawel J; Dankelmann E; Duell T; Faderl B; Markus A; Siakavara M; Wagner H; Feldmann K; Hoffmann H; Raith H; Nagel D; Stieber P
    Clin Cancer Res; 2008 Dec; 14(23):7813-21. PubMed ID: 19047109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum tumour markers CEA, AFP, CA 15-3, TPS and Neu in diagnosis of breast cancer.
    Eskelinen M; Kataja V; Hämäläinen E; Kosma VM; Penttilä I; Alhava E
    Anticancer Res; 1997; 17(2B):1231-4. PubMed ID: 9137478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Values and limits of combined use of 4 tumor markers (CEA, TPA, NSE and SCC) in un-treated patients with lung cancer.
    Cuomo A; Capra R; Greco S; Cacciani GC; Greco F; Franchini D; Bonelli P; Gavaruzzi G; Ugolotti G
    Acta Biomed Ateneo Parmense; 1993; 64(5-6):171-84. PubMed ID: 7992555
    [No Abstract]   [Full Text] [Related]  

  • 39. The prognostic value of both neuron-specific enolase (NSE) and Cyfra21-1 in small cell lung cancer.
    Ando S; Suzuki M; Yamamoto N; Iida T; Kimura H
    Anticancer Res; 2004; 24(3b):1941-6. PubMed ID: 15274381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pro-gastrin-releasing peptide (ProGRP)--a useful marker in small cell lung carcinomas.
    Stieber P; Dienemann H; Schalhorn A; Schmitt UM; Reinmiedl J; Hofmann K; Yamaguchi K
    Anticancer Res; 1999; 19(4A):2673-8. PubMed ID: 10470218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.